MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$78,537K
EPS
-$5.9
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
70,095
General and administrative
15,215
Total operating expenses
85,310
Operating loss
-85,310
Interest and investment income, net
5,530
Interest expense
0
Other income, net
1,243
Total other income, net
6,773
Net loss
-78,537
Basic EPS
-5.9
Diluted EPS
-5.9
Basic Average Shares
13,317,116
Diluted Average Shares
13,317,116
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest and investmentincome, net$5,530K Other income, net$1,243K Net loss-$78,537K Total other income,net$6,773K Operating loss-$85,310K Total operatingexpenses$85,310K Research and development$70,095K General andadministrative$15,215K

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (CRBP)